Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has submitted a certificate from its Registrar and Transfer Agent (Bigshare Services Pvt. Ltd.) under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The RTA confirmed that this regulation is not applicable to the company because the entire shareholding of the company is already held in demat (electronic) form. Additionally, no requests for rematerialisation (converting demat shares back to physical form) were received from any shareholder during the quarter. The filing was signed by Chairman and Managing Director Jagdish Umakant Nayak and is a routine quarterly compliance requirement.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that all shares are in electronic form and there were no conversion requests during the quarter.